131 related articles for article (PubMed ID: 28178049)
1. Single Health System Adherence to 2012 Cervical Cancer Screening Guidelines at Extremes of Age and Posthysterectomy.
Teoh D; Isaksson Vogel R; Hultman G; Monu M; Downs L; Geller MA; Le C; Melton-Meaux G; Kulasingam S
Obstet Gynecol; 2017 Mar; 129(3):448-456. PubMed ID: 28178049
[TBL] [Abstract][Full Text] [Related]
2. Effect of an Electronic Health Record Decision Support Alert to Decrease Excess Cervical Cancer Screening.
Teoh D; Vogel RI; Langer A; Bharucha J; Geller MA; Harwood E; Kulasingam S; Melton GB
J Low Genit Tract Dis; 2019 Oct; 23(4):253-258. PubMed ID: 31592972
[TBL] [Abstract][Full Text] [Related]
3. Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid.
Parekh N; Donohue JM; Men A; Corbelli J; Jarlenski M
Obstet Gynecol; 2017 Jan; 129(1):66-75. PubMed ID: 27926644
[TBL] [Abstract][Full Text] [Related]
4. Differences in cervical cancer screening and follow-up for black and white women in the United States.
Ford S; Tarraf W; Williams KP; Roman LA; Leach R
Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
[TBL] [Abstract][Full Text] [Related]
5. Excess Cost of Cervical Cancer Screening Beyond Recommended Screening Ages or After Hysterectomy in a Single Institution.
Teoh D; Hultman G; DeKam M; Isaksson Vogel R; Downs LS; Geller MA; Le C; Melton G; Kulasingam S
J Low Genit Tract Dis; 2018 Jul; 22(3):184-188. PubMed ID: 29733302
[TBL] [Abstract][Full Text] [Related]
6. Screening with Papanicolaou tests in Alberta: Are we Choosing Wisely?
Symonds CJ; Chen W; Rose MS; Cooke LJ
Can Fam Physician; 2018 Jan; 64(1):47-53. PubMed ID: 29358254
[TBL] [Abstract][Full Text] [Related]
7. Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013-2014.
Luque JS; Tarasenko YN; Chen C
J Prim Prev; 2018 Aug; 39(4):329-344. PubMed ID: 29876723
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
Qin J; Saraiya M; Martinez G; Sawaya GF
JAMA Intern Med; 2020 Feb; 180(2):274-280. PubMed ID: 31904768
[TBL] [Abstract][Full Text] [Related]
9. Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines.
Tsui J; Hofstetter AM; Soren K
Prev Med; 2014 Jun; 63():81-6. PubMed ID: 24650625
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
11. Adherence to the 2012 national cervical cancer screening guidelines: a pilot study.
Teoh DG; Marriott AE; Isaksson Vogel R; Marriott RT; Lais CW; Downs LS; Kulasingam SL
Am J Obstet Gynecol; 2015 Jan; 212(1):62.e1-9. PubMed ID: 24992692
[TBL] [Abstract][Full Text] [Related]
12. Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
Qin J; Shahangian S; Saraiya M; Holt H; Gagnon M; Sawaya GF
Gynecol Oncol; 2021 Nov; 163(2):378-384. PubMed ID: 34507826
[TBL] [Abstract][Full Text] [Related]
13. Use of the Papanicolaou test in women under 25 years of age in Southern Alberta.
Snodgrass R; Naugler C
J Obstet Gynaecol Can; 2014 Apr; 36(4):320-3. PubMed ID: 24798669
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening among women by hysterectomy status and among women aged ≥65 years - United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1043-7. PubMed ID: 23282862
[TBL] [Abstract][Full Text] [Related]
15. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
White MC; Shoemaker ML; Benard VB
Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening after 50: near extinction?
Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening among vulnerable women: factors affecting guideline adherence at a community health centre in Toronto, Ont.
Wiedmeyer ML; Lofters A; Rashid M
Can Fam Physician; 2012 Sep; 58(9):e521-6. PubMed ID: 22972744
[TBL] [Abstract][Full Text] [Related]
18. Roles of Health Care Providers and Patients in Initiation of Unnecessary Papanicolaou Testing After Total Hysterectomy.
Guo F; Kuo YF
Am J Public Health; 2016 Nov; 106(11):2005-2011. PubMed ID: 27631753
[TBL] [Abstract][Full Text] [Related]
19. Demographic factors associated with overuse of Pap testing.
Kepka D; Breen N; King JB; Meissner HI; Roland KB; Benard VB; Saraiya M
Am J Prev Med; 2014 Nov; 47(5):629-33. PubMed ID: 25175763
[TBL] [Abstract][Full Text] [Related]
20. Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.
Yabroff KR; Saraiya M; Meissner HI; Haggstrom DA; Wideroff L; Yuan G; Berkowitz Z; Davis WW; Benard VB; Coughlin SS
Ann Intern Med; 2009 Nov; 151(9):602-11. PubMed ID: 19884621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
